Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Research & Development: 2015-2024

Historic Research & Development for Niagen Bioscience (NAGE) over the last 10 years, with Dec 2024 value amounting to $6.0 million.

  • Niagen Bioscience's Research & Development rose 39.15% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.9 million, marking a year-over-year increase of 1.28%. This contributed to the annual value of $6.0 million for FY2024, which is 21.34% up from last year.
  • According to the latest figures from FY2024, Niagen Bioscience's Research & Development is $6.0 million, which was up 21.34% from $5.0 million recorded in FY2023.
  • In the past 5 years, Niagen Bioscience's Research & Development ranged from a high of $6.0 million in FY2024 and a low of $3.4 million during FY2020.
  • Moreover, its 3-year median value for Research & Development was $5.0 million (2023), whereas its average is $5.3 million.
  • Per our database at Business Quant, Niagen Bioscience's Research & Development decreased by 22.74% in 2020 and then increased by 25.94% in 2022.
  • Over the past 5 years, Niagen Bioscience's Research & Development (Yearly) stood at $3.4 million in 2020, then rose by 12.21% to $3.8 million in 2021, then grew by 25.94% to $4.8 million in 2022, then climbed by 2.74% to $5.0 million in 2023, then climbed by 21.34% to $6.0 million in 2024.